(19)
(11) EP 4 373 474 A1

(12)

(43) Date of publication:
29.05.2024 Bulletin 2024/22

(21) Application number: 22751726.5

(22) Date of filing: 20.07.2022
(51) International Patent Classification (IPC): 
A61K 9/20(2006.01)
A61K 31/4184(2006.01)
A61K 31/404(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/2086; A61K 31/404; A61K 31/4184; A61K 2300/00
(86) International application number:
PCT/EP2022/070332
(87) International publication number:
WO 2023/001880 (26.01.2023 Gazette 2023/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 22.07.2021 SI 202100143
01.10.2021 EP 21200559

(71) Applicant: KRKA, D.D., Novo Mesto
8501 Novo mesto (SI)

(72) Inventors:
  • KASTELIC, pela
    8501 Novo mesto (SI)
  • ZADNIK, Jernej
    8501 Novo mesto (SI)
  • HROVAT, Irena
    8501 Novo mesto (SI)
  • SLANC VOVK, Janika
    8501 Novo mesto (SI)
  • RITLOP, Gregor
    8501 Novo mesto (SI)

(74) Representative: Kutzenberger Wolff & Partner 
Waidmarkt 11
50676 Köln
50676 Köln (DE)

   


(54) BILAYER TABLET COMPRISING TELMISARTAN AND INDAPAMIDE